1. WHO . Monkeypox, COVID-19 & Other Global Health Issues Virtual Press conference transcript, 2022. Available: https://www.who.int/publications/m/item/monkeypox-covid-19-other-global-health-issues-virtual-press-conference-transcript-17-august-2022 [Accessed 31 Aug 2022].
2. Gruber MF . Overview of Available Vaccines against Smallpox & Monkeypox. Presentation to WHO R&D Blueprint Meeting: “Monkeypox research: What are the knowledge gaps and priority research questions ?”, 2022. Available: https://cdn.who.int/media/docs/default-source/blue-print/day-2_marion-gruber_vaccines_monkeypox-meeting_03june2022.pdf?sfvrsn=7b8c4d64_3 [Accessed 31 Aug 2022].
3. Cavaleri M . Overview of available therapeutics, those in the pipeline, and approaches to evaluate their efficacy. Presentation to WHO R&D Blueprint Meeting: “Monkeypox research: What are the knowledge gaps and priority research questions?”, 2022. Available: https://cdn.who.int/media/docs/default-source/blue-print/day-2_marco-cavaleri_therapeutics_monkeypox-meeting_03june2022.pdf?sfvrsn=ceeb0b8a_3 [Accessed 31 Aug 2022].
4. WHO . WHO director General's statement following IHR emergency Committee regarding the multi-country outbreak of monkeypox; 2022. https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022 [Accessed 31 Aug 2022].
5. WHO . White paper consultation: strengthening the global architecture for health emergency preparedness, response and resilience; 2022. https://www.who.int/publications/m/item/white-paper-consultation-strengthening-the-global-architecture-for-health-emergency-preparedness-response-and-resilience [Accessed 31 Aug 2022].